I also think this opens us up for a much more lucr
Post# of 72440
(Total Views: 404)
Posted On: 11/25/2019 10:00:19 AM
I also think this opens us up for a much more lucrative license agreement. Possibly the potential pharma that will take this on wanted exactly this.
The granting of this waiver now enables the Company to develop Brilacidin in a more focused manner in adult patient populations where Oral Mucositis has the greatest impact.
The granting of this waiver now enables the Company to develop Brilacidin in a more focused manner in adult patient populations where Oral Mucositis has the greatest impact.
(7)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼